Barclays initiates coverage on Thermo Fisher Scientific (NYSE: TMO) with a Overweight.

Barclays analyst says, "Based on management commentary, the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE